Johnson & Johnson has said it will stop selling talc-based baby powder products globally next year, two years after halting sales in the US and Canada.
Johnson & Johnson has agreed to pay more than $100 million to settle over 1,000 lawsuits that allege the company’s Baby Powder talc products caused cancer, according to Bloomberg.
Johnson & Johnson lawyers are gearing up to appeal a court ruling, which rewarded billions to 22 women in a case linking ovarian cancer and use of J&J's signature Baby Powder.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh